Skip to main content
. 2021 Aug 5;19(3):656–665. doi: 10.1111/iwj.13663

TABLE 1.

Comparisons between SSI and non‐SSI group in terms of demographics, patient, injury surgery variables and the biomarkers measured at admission

Variable Non‐SSI group (n = 876) SSI group (n = 24) P value
Sex (male) 812 (92.7) 23 (95.8) .558
Age (years) 41.9 ± 11.2 41.5 ± 8.7 .863
≤45 518 (59.1) 15 (62.5) .740
BMI (kg/m2) 25.1 ± 3.5 26.8 ± 3.6 .023
≥26.4 (vs <26.4) 273 (31.2) 15 (62.5) .001
≥28.0 (vs <28.0) 150 (17.1) 8 (33.3) .039
Occupation .857
Office work 109 (12.4) 2 (7.7)
Labouring 448 (51.3) 15 (62.5)
Retirement 67 (7.6) 2 (7.7)
Manual work 150 (17.2) 3 (12.5)
Others 102 (11.7) 4 (15.4)
Attainment of education (years) .570
Illiteracy 57 (6.5) 2 (8.3)
<6 227 (25.9) 9 (37.5)
6‐11.9 482 (55.0) 11 (45.8)
≥12 110 (12.6) 2 (8.3)
Current smoking 135 (15.4) 8 (33.3) .018
Current drinking 278 (31.7) 9 (37.5) .550
Hypertension 76 (8.7) 3 (12.5) .514
Diabetes mellitus 42 (4.8) 2 (8.3) .754
Heart or cardiovascular disease 23 (2.4) 1 (4.2) 1.000
History of any surgery 32 (3.7) 2 (8.3) .235
Injury mechanism (high‐impact trauma) 625 (71.3) 21 (87.5) .107
Fracture types (Sanders grades) .953
II 445 (50.8) 14 (56.5)
III 288 (32.9) 7 (30.4)
IV 143 (16.3) 3 (13.0)
Time from injury to operation (day) 8.0 ± 4.6 8.0 ± 4.9 .990
<7 352 (40.2) 10 (41.7) .413
7‐10 337 (38.5) 6 (25.0)
11‐14 128 (14.6) 5 (20.8)
>14 59 (6.7) 3 (12.5)
Length of hospital stay 16.1 ± 8.5 24.1 ± 24.6 .001
Operative time 126.7 ± 70.8 134.2 ± 79.2 .610
Intraoperative blood loss 167.9 ± 186.9 172.6 ± 113.9 .905
Incision level .023
I 845 (96.5) 21 (87.5)
II 31 (3.5) 3 (12.5)
ASA grade .089
I 153 (17.5) 1 (4.2)
II or greater 723 (82.5) 23 (95.8)
Anaesthesia mode .848
Regional (epidural/spinal) 679 (77.5) 19 (79.2)
General 197 (22.5) 5 (20.8)
Surgical approach .371
Tarsal sinus approach 256 (29.2) 5 (20.8)
Extended lateral approach 620 (70.8) 19 (79.2)
Bone‐grafting .454
Yes 72 (8.2) 3 (12.5)
No 804 (91.8) 21 (87.5)
Drainage use 353 (40.3) 7 (29.2) .272
Allogeneic blood transfusion 69 (7.9) 4 (16.7) .120
TP (g/L) 65.0 ± 6.1 67.8 ± 5.7 .024
<60 g/L 165 (18.8) 1 (4.2) .068
Albumin (g/L) 41.2 ± 5.1 44.4 ± 2.9 .002
<35 g/L 95 (10.8) 0 .171
HCRP (mg/L) 30 ± 33.6 26.2 ± 44.8 .603
>8 mg/L 604 (68.9) 13 (54.2) .124
LDH (U/L) 235.7 ± 117.7 223.2 ± 53.3 .605
>250 U/L 292 (33.3) 10 (41.7) .394
Sodium concentration (mmol/L) 139.0 ± 3.2 139.9 ± 2.5 .167
<135 mmol/L 202 (23.1) 1 (4.2) .029
FBG (mmol/L) 5.8 ± 1.5 5.6 ± 1.2 .663
≥6.1 mmol/L 192 (21.9) 6 (25.0) .719
WBC (×109/L) 8.9 ± 2.6 10.1 ± 3.3 .036
>10 × 109/L 331 (37.8) 14 (58.3) .041
Neutrophil (109/L) 6.5 ± 2.4 7.8 ± 3.3 .011
>6.3 × 109/L 413 (47.1) 15 (62.5) .137
Lymphocyte (×109/L) 1.6 ± 0.6 1.5 ± 0.5 .444
<1.1 × 109/L 162 (18.5) 6 (25.0) .420
platelet (×109/L) 228.3 ± 79.7 229.1 ± 62.3 .960
>300 × 109/L 124 (14.2) 5 (20.8) .357
NLR 4.8 ± 3.1 6.0 ± 3.8 .044
<6.4 696 (79.5) 14 (58.3) .012
≥6.4 180 (20.5) 10 (41.7)
PLR 160.5 ± 83.9 162.1 ± 48.2 .927
<150 518 (59.1) 10 (41.7) .086
≥150 358 (40.9) 14 (58.3)
RBC (×1012/L) 4.2 ± 0.6 4.5 ± 0.5 .089
<Lower limit 168 (19.2) 2 (8.3) .181
Haemoglobin (g/L) 134.5 ± 17.3 138.5 ± 14.4 .256
<Lower limit 117 (13.4) 2 (8.3) .474
HCT (percentage) 39.7 ± 5.3 40.9 ± 4.1 .280
<Lower limit 120 (13.7) 4 (2.7) .677

Note: Data presentation, mean ± SD (standard deviation) or number (percentage); BMI, body mass index; ASA, American Society of Anesthesiologists; TP, total protein; HCRP, hyper‐sensitive C‐reaction protein; HDH, lactate dehydrogenase; WBC, white blood cell; FBG, fasting blood glucose; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; RBC, red blood cell, reference range: female, 3.5 to 5.0 × 1012/L; male, 4.0 to 5.5 × 1012/L. Haemoglobin, reference range: Female, 110 to 150 g/L; male, 120 to 160 g/L. HCT, haematocrit, reference range: female, 35% to 45%; male, 40% to 50%.